Finding undervalued stocks is the best way to maximize stock returns. The following three Canadian stocks are currently in value territory and deserve attention.
Agnico-Eagle Mines Ltd. is a major Canadian gold producer, with its gold mines strategically located in safe, mining-supportive jurisdictions across Canada, Europe, and parts of Latin America. Gold prices have risen significantly over the past few years, with a cumulative increase of approximately 144% over the past five years—a trend that is hardly surprising given the current geopolitical backdrop and uncertain economic environment. Benefiting from rising gold prices and its own solid operational performance, Agnico-Eagle Mines’ share price has climbed accordingly. In the first quarter of 2026, the company achieved record net profits, with adjusted net income reaching $1.7 billion and earnings per share of $3.41, representing a 120% increase year-over-year.
Since the outbreak of the pandemic, Cineplex Inc. has struggled to recapture its former glory, and the rise of streaming services has made things even more difficult for this undervalued stock over the past few years. However, signs of a recovery are now emerging at Cineplex. In the first quarter of 2026, the company recorded 9.8 million admissions, up 17.3% year-over-year; box office revenue in May reached CAD 60.5 million, the highest level since 2019 and a 9.4% increase compared to the same period last year. Year-to-date total box office revenue stands at CAD 120.5 million, up 12.9% year-over-year. Although the road to recovery is long, patient investors stand to be rewarded.
Well Health Technologies Corp. is a technology company focused on the healthcare sector, dedicated to integrating and empowering healthcare providers through digital tools. The company operates one of Canada’s largest networks of primary care clinics and has a rapidly growing U.S. business. Well Health expects full-year 2026 normalized revenue growth of 15% to 22%, with EBITDA projected between CAD 175 million and CAD 185 million. Among its segments, the Canadian division—which includes primary care operations—has already surpassed management’s annual expectations, recently achieving its target of CAD 100 million in annualized revenue, driven by organic expansion and two value-accretive acquisitions. As a result, the company’s official guidance will be revised upward, with EBITDA expected to exceed CAD 185 million, with a specific update to be announced during the second-quarter earnings release in August.
Currently, Well Health Technologies’ share price trades below 20 times this year’s expected earnings. Beyond its attractive valuation, the company’s growth continues to exceed expectations, and its profitability is rapidly improving, making it one of the most compelling buys on the Toronto Stock Exchange at present. Agnico-Eagle Mines, supported by high gold prices and record quarterly results, and Cineplex, benefiting from a clear rebound in theater traffic, both demonstrate strong investment value. These three stocks come from the gold mining, entertainment, and digital health sectors, respectively, and each has been undervalued due to industry cycles, market sentiment, or external shocks. However, their fundamentals are now sending positive signals, offering investors an opportunity to position themselves ahead of a potential reversal in consensus sentiment.
